Results 71 to 80 of about 11,258 (167)
Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases
B Acute Lymphoblastic leukemia (B-ALL) with Philadelphia chromosome (Ph') is a neoplasm of lymphoblast committed to the B cell lineage. The clinical presentation of B-ALL Ph'+ is similar to B-ALL, but is more common in adults than in children. The e1a3 rare variant is produced by the fusion of BCR exon 1 to ABL exon 3.
Lopez-Andrade, Bernardo +12 more
openaire +1 more source
Flow cytometric detection of BCR-ABL fusion proteins in leukemia patients via an immunobead assay
Peer ...
Weerkamp, F. +2 more
openaire +1 more source
Chronic myelogenous leukemia (CML) presents a unique opportunity to develop therapeutic strategies using vaccination against a truly tumor-specific antigen that is also the oncogenic protein required for neoplasia. We have shown in phase I and II trials that a tumor-specific, bcr-abl-derived peptide vaccine can be safely administered to patients with ...
Javier, Pinilla-Ibarz +4 more
openaire +1 more source
The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment] [PDF]
openaire +1 more source
Fusion oncoproteins orchestrate tumorigenesis and sustain malignant progression via a positive feedback mechanism. [PDF]
Ying W +7 more
europepmc +1 more source
Non-receptor tyrosine kinase signaling pathways and therapeutic implications. [PDF]
Hossain MDA +4 more
europepmc +1 more source
Identification of a <i>Musashi2</i> translocation as a novel oncogene in myeloid leukemia. [PDF]
Spinler K +6 more
europepmc +1 more source
Proximity-Induced Rewiring of Oncogenic Kinase Triggers Apoptosis. [PDF]
Merz ML +26 more
europepmc +1 more source

